Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/177973
Full metadata record
DC FieldValueLanguage
dc.contributor.authorRubio-Rivas, Manuel-
dc.contributor.authorCorbella, Xavier-
dc.contributor.authorFormiga Pérez, Francesc-
dc.contributor.authorMenéndez Fernández, Estela-
dc.contributor.authorMartín Escalante, María Dolores-
dc.contributor.authorBaños Fernández, Isolina-
dc.contributor.authorArnalich Fernández, Francisco-
dc.contributor.authorCorral-Beamonte, Esther del-
dc.contributor.authorLalueza, Antonio-
dc.contributor.authorParra Virto, Alejandro-
dc.contributor.authorRoy Vallejo, Emilia-
dc.contributor.authorLoureiro Amigo, José-
dc.contributor.authorÁlvarez Suárez, Ana María-
dc.contributor.authorAbadía-Otero, Jesica-
dc.contributor.authorNavarro de la Chica, María-
dc.contributor.authorEstévez González, Raquel-
dc.contributor.authorHernández Milián, Almudena-
dc.contributor.authorAreses Manrique, María-
dc.contributor.authorBlázquez Encinar, Julio César-
dc.contributor.authorGonzález Noya, Amara-
dc.contributor.authorGonzález Ferrer, Ruth-
dc.contributor.authorPérez Aguilera, María-
dc.contributor.authorGil Sánchez, Ricardo-
dc.contributor.authorMillán Núñez-Cortés, Jesús-
dc.contributor.authorCasas Rojo, José-
dc.contributor.authorSEMI-COVID-19 Network-
dc.date.accessioned2021-06-03T16:02:00Z-
dc.date.available2021-06-03T16:02:00Z-
dc.date.issued2021-05-01-
dc.identifier.issn2077-0383-
dc.identifier.urihttp://hdl.handle.net/2445/177973-
dc.description.abstractBackground: the inflammation or cytokine storm that accompanies COVID-19 marks the prognosis. This study aimed to identify three risk categories based on inflammatory parameters on admission. Methods: retrospective cohort study of patients diagnosed with COVID-19, collected and followed-up from 1 March to 31 July 2020, from the nationwide Spanish SEMI-COVID-19 Registry. The three categories of low, intermediate, and high risk were determined by taking into consideration the terciles of the total lymphocyte count and the values of C-reactive protein, lactate dehydrogenase, ferritin, and D-dimer taken at the time of admission. Results: a total of 17,122 patients were included in the study. The high-risk group was older (57.9 vs. 64.2 vs. 70.4 years; p < 0.001) and predominantly male (37.5% vs. 46.9% vs. 60.1%; p < 0.001). They had a higher degree of dependence in daily tasks prior to admission (moderate-severe dependency in 10.8% vs. 14.1% vs. 17%; p < 0.001), arterial hypertension (36.9% vs. 45.2% vs. 52.8%; p < 0.001), dyslipidemia (28.4% vs. 37% vs. 40.6%; p < 0.001), diabetes mellitus (11.9% vs. 17.1% vs. 20.5%; p < 0.001), ischemic heart disease (3.7% vs. 6.5% vs. 8.4%; p < 0.001), heart failure (3.4% vs. 5.2% vs. 7.6%; p < 0.001), liver disease (1.1% vs. 3% vs. 3.9%; p = 0.002), chronic renal failure (2.3% vs. 3.6% vs. 6.7%; p < 0.001), cancer (6.5% vs. 7.2% vs. 11.1%; p < 0.001), and chronic obstructive pulmonary disease (5.7% vs. 5.4% vs. 7.1%; p < 0.001). They presented more frequently with fever, dyspnea, and vomiting. These patients more frequently required high flow nasal cannula (3.1% vs. 4.4% vs. 9.7%; p < 0.001), non-invasive mechanical ventilation (0.9% vs. 3% vs. 6.3%; p < 0.001), invasive mechanical ventilation (0.6% vs. 2.7% vs. 8.7%; p < 0.001), and ICU admission (0.9% vs. 3.6% vs. 10.6%; p < 0.001), and had a higher percentage of in-hospital mortality (2.3% vs. 6.2% vs. 23.9%; p < 0.001). The three risk categories proved to be an independent risk factor in multivariate analyses. Conclusion: the present study identifies three risk categories for the requirement of high flow nasal cannula, mechanical ventilation, ICU admission, and in-hospital mortality based on lymphopenia and inflammatory parameters.-
dc.format.extent13 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherMDPI-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.3390/jcm10102214-
dc.relation.ispartofJournal of Clinical Medicine, 2021, vol. 10, num. 10, p. 2214-
dc.relation.urihttps://doi.org/10.3390/jcm10102214-
dc.rightscc-by (c) Rubio-Rivas, Manuel et al., 2021-
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/-
dc.sourceArticles publicats en revistes (Ciències Clíniques)-
dc.subject.classificationCOVID-19-
dc.subject.classificationCitoquines-
dc.subject.classificationMortalitat-
dc.subject.otherCOVID-19-
dc.subject.otherCytokines-
dc.subject.otherMortality-
dc.titleRisk categories in COVID-19 based on degrees of inflammation: data on more than 17,000 patients from the Spanish SEMI-COVID-19 registry-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.identifier.idgrec712249-
dc.date.updated2021-06-03T16:02:00Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.pmid34065316-
Appears in Collections:Articles publicats en revistes (Ciències Clíniques)
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
712249.pdf1.26 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons